hydrochlorothiazide has been researched along with EBV Infections in 1 studies
Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Prtajin, M | 1 |
Ljubojević Hadžavdić, S | 1 |
1 other study available for hydrochlorothiazide and EBV Infections
Article | Year |
---|---|
Pityriasis Rosea after COVID-19 Infection.
Topics: COVID-19; COVID-19 Vaccines; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Herpesvirus 6, Hum | 2022 |